This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kendig, J. W.
Right arrow Articles by Phelps, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kendig, J. W.
Right arrow Articles by Phelps, D. L.
Related Collections
Right arrow Premature & Newborn

PEDIATRICS Vol. 101 No. 6 June 1998, pp. 1006-1012

Comparison of Two Strategies for Surfactant Prophylaxis in Very Premature Infants: A Multicenter Randomized Trial

Received Apr 3, 1997; accepted Oct 2, 1997.

James W. Kendig*, Rita M. Ryan*, Robert A. Sinkin*, William M. Maniscalco*, Robert H. Notter*, Ronnie Guillet*, Christopher CoxDagger , Harry S. Dweckparallel , Michael J. Horgan§, Linda J. Reubens*, Herman Risemberg§, and Dale L. Phelps*

From the Rochester Surfactant Trials Group, the * Department of Pediatrics, Division of Neonatology, Children's Hospital at Strong, Rochester, New York; the Dagger  Department of Biostatistics, Strong Children's Research Center, University of Rochester School of Medicine and Dentistry, Rochester, New York; the § Department of Pediatrics, Section of Neonatal Medicine, Children's Hospital at Albany, Albany Medical College, Albany, New York; and the parallel  Department of Pediatrics, Division of Neonatal-Perinatal Medicine, New York Medical College, Westchester Medical Center, Valhalla, New York.

Introduction.  Previous trials of surfactant therapy in premature infants have demonstrated a survival advantage associated with prophylactic therapy as an immediate bolus, compared with the rescue treatment of established respiratory distress syndrome. The optimal strategy for prophylactic therapy, however, remains controversial. When administered as an endotracheal bolus immediately after delivery, surfactant mixes with the absorbing fetal lung fluid and may reach the alveoli before the onset of lung injury. This approach, however, causes a brief delay in the initiation of standard neonatal resuscitation, including positive pressure ventilation, and is associated with a risk for surfactant delivery into the right main stem bronchus or esophagus. As an alternative approach, surfactant prophylaxis may be administered in small aliquots soon after resuscitation and confirmation of endotracheal tube position. Although this strategy has substantial logistical advantages in clinical practice, its efficacy has not been established.

Objective.  The purpose of this study was to determine whether the established benefits of the immediate bolus strategy for surfactant prophylaxis could still be achieved using a postventilatory aliquot strategy after initial standard resuscitation and stabilization.

Design.  Multicenter randomized clinical trial with patients randomized before delivery to immediate bolus or postventilatory aliquot therapy.

Participants.  Inborn premature infants delivered to mothers at an estimated gestational age of 24[<FR><NU>0</NU><DE>7</DE></FR>] to 28[<FR><NU>6</NU><DE>7</DE></FR>] weeks.

Interventions.  Those infants who were randomized to the immediate bolus strategy were intubated as rapidly as possible after birth, and a 3-mL intratracheal bolus of calf lung surfactant extract (Infasurf) was administered before the initiation of positive pressure ventilation. Those infants who were randomized to the postventilatory aliquot strategy received standard resuscitation measures with intubation by 5 minutes of age, if not required earlier. At 10 minutes after birth, 3 mL of surfactant was administered in 4 divided aliquots of 0.75 mL each. Patients in both groups were eligible to receive up to three additional doses of surfactant as rescue therapy in the neonatal intensive care unit, if needed.

Outcome Measures.  The primary outcome variable was survival to discharge to home. Secondary variables included neonatal complications and requirement for oxygen therapy at 36 weeks' postmenstrual age.

Results.  Among three centers, 651 infants were enrolled and randomized before delivery. Survival to discharge to home was similar for the two strategies for surfactant therapy as prophylaxis: 76% for the immediate bolus group and 80% for the postventilatory aliquot group. In a secondary analysis, the rate of supplemental oxygen administration at 36 weeks' postmenstrual age was 18% for the immediate bolus group and 13% for the postventilatory aliquot group.

Conclusions.  Survival to discharge to home was similar with immediate bolus and postventilatory aliquot strategies for surfactant prophylaxis. Because of its logistical advantages in the delivery room and its beneficial effects on prolonged oxygen requirements, we recommend the postventilatory aliquot strategy for surfactant prophylaxis of premature infants delivered before 29 weeks' gestation.

Key words: infant, premature, respiratory distress syndrome, pulmonary surfactants, randomized controlled trials.




This article has been cited by other articles:


Home page
 PediatricsHome page
W. A. Engle and and the Committee on Fetus and Newborn
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Pediatrics, February 1, 2008; 121(2): 419 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
N. H. Hillman, T. J. M. Moss, S. G. Kallapur, C. Bachurski, J. J. Pillow, G. R. Polglase, I. Nitsos, B. W. Kramer, and A. H. Jobe
Brief, Large Tidal Volume Ventilation Initiates Lung Injury and a Systemic Response in Fetal Sheep
Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 575 - 581.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
T. A. Leone and N. N. Finer
Neonatal Resuscitation: Beyond the Basics
NeoReviews, April 1, 2005; 6(4): e177 - e183.
[Full Text] [PDF]

Home page
 PediatricsHome page
N. N. Finer, W. A. Carlo, S. Duara, A. A. Fanaroff, E. F. Donovan, L. L. Wright, S. Kandefer, W. K. Poole, and for the National Institute of Child Health and Hum
Delivery Room Continuous Positive Airway Pressure/Positive End-Expiratory Pressure in Extremely Low Birth Weight Infants: A Feasibility Trial
Pediatrics, September 1, 2004; 114(3): 651 - 657.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
P. Carteaux, H. Cohen, J. Check, J. George, P. McKinley, W. Lewis, P. Hegwood, J. M. Whitfield, D. McLendon, S. Okuno-Jones, et al.
Evaluation and Development of Potentially Better Practices for the Prevention of Brain Hemorrhage and Ischemic Brain Injury in Very Low Birth Weight Infants
Pediatrics, April 1, 2003; 111(4): e489 - 496.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. A. Osborn, H. E. Jeffery, S. L. Bredemeyer, J. M. Polverino, and S. Reid
Targeted Early Rescue Surfactant in Ventilated Preterm Infants Using the Click Test
Pediatrics, September 1, 2000; 106(3): 30e - 30.
[Abstract] [Full Text]

Home page
 PediatricsHome page
R. A. Sinkin, H. S. Dweck, M. J. Horgan, K. J. Gallaher, C. Cox, W. M. Maniscalco, P. R. Chess, C. T. D'Angio, R. Guillet, J. W. Kendig, et al.
Early Dexamethasone---Attempting To Prevent Chronic Lung Disease
Pediatrics, March 1, 2000; 105(3): 542 - 548.
[Abstract] [Full Text]